Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 9, 2015

View Archived Issues

Researchers create first synthetic vascular repair graft composed of three layers

New safety data on PAT-SM6 in multiple myeloma patients

Brickell Biotech holds financing round, begins study of BBI-4000

BP-2001 reprograms intestinal cells into insulin-secreting cells in diabetes model

FDA to review sNDA for psoriasis candidate tofacitinib

Eisai updates on its Alzheimer's disease collaboration with Biogen Idec

EMA grants orphan drug status to Theravectys vaccine for ATL/L

QR Pharma and Rockefeller University collaborate to test Posiphen in HD models

Actavis to divest rights to respiratory portfolio in U.S. and Canada to AstraZeneca

Akaal Pharma reports data from phase I trial of AKP-11 in psoriasis

Isis Pharmaceuticals earns milestone payment from Biogen Idec for advancing ISIS-BIIB4Rx

UCB reports topline data from phase III program of Neupro in Parkinson's disease

Sanofi targets U.S. Lyxumia submission and LixiLan filings

Bristol-Myers Squibb discloses new IDO inhibitors

Universidad de Alcala patents treatments for leishmania and/or PTP-1B-related diseases

The University of Copenhagen patents iGluR antagonists

Inhibitors for mutant IDH2 disclosed by Agios Pharmaceuticals

Valeant amends Dendreon stalking horse asset purchase agreement

Allergan patent reports FPR2 modulators

RXi Pharmaceuticals acquires Samcyprone from Hapten Pharmaceuticals

CrystalGenomics' polmacoxib approved in South Korea for osteoarthritis

Daiichi Sankyo starts Asian phase III trial program for mirogabalin

FDA advisory committee sets March date to discuss Breo Ellipta filing

FDA approves Lucentis for diabetic retinopathy in patients with diabetic macular edema

Pfizer agrees to acquire Hospira

European Commission approves Velcade for mantle cell lymphoma

GSK files for E.U. approval of eltrombopag for treatment of chronic ITP in children

Daiichi Sankyo launches Savaysa in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...